Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Rubius Therapeutics Inc.
About RUBY
Rubius Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing medicines called Red Cell Therapeutics (RCTs). Its RED PLATFORM is designed to genetically engineer, and culture Red Cell Therapeutics that are ready-to-use cellular therapies for the treatment of cancer and autoimmune diseases. It develops RCT product candidates based on therapeutic modalities such as immune system stimulation for the treatment of cancer and immune modulation to induce tolerance in autoimmune diseases. Its oncology program, RTX-240, is in the Phase I/II clinical trial for relapsed/refractory or solid tumors and in the Phase I clinical trial for relapsed/refractory acute myeloid leukemia (AML). Its RTX-321 is an allogeneic artificial antigen presenting cell (aAPC) product candidate, which is in the Phase I clinical trial for the treatment of advanced human papillomavirus (HPV) 16-positive cancers.
Find out what a historical investment in Rubius Therapeutics Inc. would be worth today using our RUBY stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy RUBY shares in Australia?
Buying RUBY shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Rubius Therapeutics Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in RUBY
What is the ticker symbol of Rubius Therapeutics Inc.?
The ticker symbol for Rubius Therapeutics Inc. is RUBY.
How much is one share of RUBY?
One share of RUBY is valued at $0.02 as of 16 May 2026.
What is the market capitalisation of Rubius Therapeutics Inc. RUBY?
As of 16 May 2026 Rubius Therapeutics Inc. has a market cap of -.
What is the 52-week high for Rubius Therapeutics Inc. stock?
The Rubius Therapeutics Inc. 52-week high stock price is $NaN.
What is the 52-week low for Rubius Therapeutics Inc. stock?
The Rubius Therapeutics Inc. 52-week low stock price is $NaN.
Can I buy RUBY shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy RUBY shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in RUBY on Stake
- Buy RUBY from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of RUBY from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
RUBY related stocks